MX2023015276A - Tratamiento para venas varicosas con agonistas del componente 1 de canales iónicos mecanosensibles de tipo piezo (piezo1). - Google Patents

Tratamiento para venas varicosas con agonistas del componente 1 de canales iónicos mecanosensibles de tipo piezo (piezo1).

Info

Publication number
MX2023015276A
MX2023015276A MX2023015276A MX2023015276A MX2023015276A MX 2023015276 A MX2023015276 A MX 2023015276A MX 2023015276 A MX2023015276 A MX 2023015276A MX 2023015276 A MX2023015276 A MX 2023015276A MX 2023015276 A MX2023015276 A MX 2023015276A
Authority
MX
Mexico
Prior art keywords
varicose veins
piezo1
ion channel
channel component
agonists
Prior art date
Application number
MX2023015276A
Other languages
English (en)
Spanish (es)
Inventor
Alexander Li
Aris Baras
Joshua Backman
Goncalo Abecasis
Manuel Allen Revez Ferreira
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2023015276A publication Critical patent/MX2023015276A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2023015276A 2021-07-08 2022-07-05 Tratamiento para venas varicosas con agonistas del componente 1 de canales iónicos mecanosensibles de tipo piezo (piezo1). MX2023015276A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163219462P 2021-07-08 2021-07-08
PCT/US2022/073441 WO2023283560A1 (en) 2021-07-08 2022-07-05 Treatment of varicose veins with piezo type mechanosensitive ion channel component 1 (piezo1) agonists

Publications (1)

Publication Number Publication Date
MX2023015276A true MX2023015276A (es) 2024-04-03

Family

ID=82748409

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023015276A MX2023015276A (es) 2021-07-08 2022-07-05 Tratamiento para venas varicosas con agonistas del componente 1 de canales iónicos mecanosensibles de tipo piezo (piezo1).

Country Status (10)

Country Link
US (1) US20230041060A1 (cg-RX-API-DMAC7.html)
EP (1) EP4367266A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024524554A (cg-RX-API-DMAC7.html)
KR (1) KR20240049797A (cg-RX-API-DMAC7.html)
CN (1) CN121175436A (cg-RX-API-DMAC7.html)
AU (1) AU2022307546A1 (cg-RX-API-DMAC7.html)
CA (1) CA3225855A1 (cg-RX-API-DMAC7.html)
IL (1) IL309694A (cg-RX-API-DMAC7.html)
MX (1) MX2023015276A (cg-RX-API-DMAC7.html)
WO (1) WO2023283560A1 (cg-RX-API-DMAC7.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL285644B2 (en) * 2019-02-18 2026-06-01 Regeneron Pharma Piezo type mechanosensitive ion channel component 1 (piezo1) variants and uses thereof

Also Published As

Publication number Publication date
CA3225855A1 (en) 2023-01-12
JP2024524554A (ja) 2024-07-05
US20230041060A1 (en) 2023-02-09
KR20240049797A (ko) 2024-04-17
WO2023283560A1 (en) 2023-01-12
EP4367266A1 (en) 2024-05-15
AU2022307546A1 (en) 2024-01-04
IL309694A (en) 2024-02-01
CN121175436A (zh) 2025-12-19

Similar Documents

Publication Publication Date Title
WO2020154268A3 (en) Treatment of ophthalmic conditions with angiopoietin-like 7 (angptl7) inhibitors
BR112022008817A2 (pt) Terapias combinadas para tratamento de câncer
MX2022011141A (es) Anticuerpos anti-coronavirus y metodos de uso.
BR112023020182A2 (pt) Métodos para tratar câncer em um sujeito em necessidade do mesmo e para inibir ras em uma célula
BR112017021305A2 (pt) dispositivo de teste de fluxo lateral, e, método e kit para detecção quantitativa de um analito em uma amostra de saliva
BR112023024942A2 (pt) Uso de inibidores de atr em combinação com inibidores de parp para tratamento de câncer
MX2023009714A (es) Metodos para el tratamiento de la perdida auditiva neurosensorial mediante el uso de sistemas de vectores duales de otoferlina.
EA202191067A1 (ru) Композиции и способы для лечения дефицита альфа-1-антитрипсина
CY1105303T1 (el) Ηλεκτροδιο βελονας
JOP20190197A1 (ar) مثبط كيناز ايه تي آر للاستخدام في طريقة لعلاج مرض فرط التكاثر
AU2020225197A8 (en) Piezo type mechanosensitive ion channel component 1 (PIEZO1) variants and uses thereof
BR112021023473A2 (pt) Vetores de terapia genética para osteopetrose maligna infantil
PT1176971E (pt) Utilizacao de phyllanthus para o tratamento de processos inflamatorios e fibroticos cronicos
BR112022006013A2 (pt) Dispositivo e método para a determinação não inva-siva de analito
DE60239012D1 (de) Verfahren zum identifizieren von mustern in biologischen systemen und deren anwendungen
MX2022014254A (es) Anticuerpos anti-hemojuvelina (hjv) para tratar mielofibrosis.
BR112021006680A2 (pt) sistema, método e dispositivo melhorados de tratamento de refluxo gastroesofágico
WO2021195470A3 (en) Identification and use of compounds in the treatment or prevention of severe acute respiratory syndrome coronavirus 2
EA202192224A1 (ru) Обработка подземных пластов
EA202192176A1 (ru) Нарушения, опосредованные интерфероном i типа
EA202090439A1 (ru) Способы и материалы для оценки и лечения рака
WO2020190608A3 (en) Treatment of hyperglycemia with solute carrier family 39 member 5 (slc39a5) inhibitors
MX2022013897A (es) Dominio kelch que contiene variantes de 7b (klhdc7b) y usos de estas.
MX2025008198A (es) Terapia con moléculas de proteínas de unión a lípidos
WO2023278787A3 (en) Treatment of decreased bone mineral density with wnt family member 5b (wnt5b) inhibitors